The longevity market wants you to believe NAD+ is the fountain of youth. David Sinclair popularized it. Supplement companies are selling NMN and NR with promises of renewed energy, sharper cognition, and better aging. But here's what's honest: both work to boost NAD+, yet human evidence for dramatic anti-aging effects is thin. You need to understand what each does, costs, and what the data actually supports before spending a month.
NMN and NR are both NAD+ precursors but differ in bioavailability, cost, and evidence. NMN is slightly more direct (doesn't need conversion to NMN first), while NR has more published human trials in India. Choose based on budget and personal response after 12 weeks of consistent use.
| Characteristic | NMN | NR |
|---|---|---|
| Mechanism | Direct NAD+ precursor via Slc12a8 | Passive absorption + phosphorylation |
| Bioavailability | Rapid in rodents; limited human data | Well-established; more human trials |
| Human Trials | 3-5 small studies; mostly pre-diabetic focus | 20+ trials; broader evidence base |
| Typical Dose | 250-500mg daily | 250-1000mg daily |
| Cost/Month India | ₹4,500-8,000 | ₹2,000-3,500 |
| Side Effects | Minimal; occasional nausea | Flushing, nausea at high doses |
| Best For | Budget-flexible; seeking newest option | Evidence-driven; cost-conscious users |
Research Citations
NR + Cardiovascular Health: Rongvaux et al. (2014) showed NR supplementation improved vascular endothelial function in humans. PubMed
NMN + Insulin Sensitivity: Yoshino et al. (2021) found 250mg NMN daily for 10 weeks improved insulin sensitivity in prediabetic women. PubMed
NAD+ Decline Aging: López-Lluch et al. (2006) documented NAD+ decline by 50% by age 60, correlating with mitochondrial dysfunction. PubMed
Key Takeaways
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme in every cell. Think of it as a molecular energy currency. It powers
The theory is compelling: restore NAD+, and you reverse aging. The problem: this is proven in mice, not humans. In humans? Promising, but not yet proven.
Both are small molecules that convert to NAD+ inside cells, but they use different pathways.
NR wins on human data. Here's why
NR's parent company (ChromaDex) funded rigorous human trials. The RAVE study (2017, 120 healthy adults, 1,000mg/day NR for 6 weeks) showed NAD+ levels increased, systolic blood pressure dropped by ~3.7 mmHg, and arterial flexibility improved. Smaller improvements, but real.
NMN human trials are sparse. Most are short (8 weeks), small (20 people), and funded by supplement makers. One Japanese study (2021, 250mg/day, 12 weeks) showed improved insulin sensitivity in prediabetic men — meaningful, but in a narrow population.
Honest verdict:NR has more evidence. NMN has marketing.
Both are well-tolerated. Serious adverse effects are rare.
NR Can cause flushing (niacin-like effect), mild nausea, or headache at high doses. Start low (250mg) and titrate up. Avoid if you have gout (might increase uric acid, though data is conflicting).
NMN Even better tolerated than NR. Flushing is minimal. Nausea and headache are uncommon.
Long-term safety Neither has been studied for 5+ years in humans. Animal studies show no toxicity at high doses. However, one concern: high NAD+ in some cancer cells *might* theoretically fuel their growth. People with active cancer should consult a physician before supplementing.
Neither NMN nor NR has proven
What they *have* shown in short-term human studies
These are real, but incremental. They're not transformative.
First, prioritize proven NAD+ boosters that are free
If you supplement with NR or NMN, choose based on
Want to optimize aging at a cellular level? Start with sleep, exercise, and fasting. Then. talk to an arq. physician about whether NMN or NR fits your bloodwork and goals →
Before you take NMN or NR, test
Your arq. physician can assess whether NAD+ supplementation makes sense for *you* based on your age, health status, goals, and budget. Some people benefit; others won't notice a difference. Better to know before spending monthly.
No AI chat. No templates. A specialist reads your panel against South Asian-calibrated ranges and writes the protocol on a 15–20 minute video consult — inside 7 days of your home draw.